Goldman Sachs Sees 40% Upside In GW Pharmaceuticals By: Benzinga via Benzinga December 14, 2017 at 11:57 AM EST Shares of cannabinoid-focused biotech company GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) are "on a path to new highs," ... Read More >> Related Stocks: Gw Pharma ADR
